Catalyst Wire Dossier Catalyst Wire Dossier

Bismuth Tripotassium Dicitrate (De-Nol)

bismuth tripotassium dicitrate · Astellas Pharma Europe B.V.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Bismuth Tripotassium Dicitrate (De-Nol), covering 2017-09-21 to 2017-09-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study To Assess The Efficacy And Safety Of Bismuth Tripotassium Dicitrate (De-Nol) In Combination With Pantoprazole And Pantoprazole Monotherapy In Treatment Of Subjects With Nonsteroidal Anti-Inflammatory Drugs (NSAID)-Induced Gastropathy [Phase 4]

See pricing